awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q27001230-CE049524-2597-4B44-8FBD-DEFA6ACBD92B
Q27001230-CE049524-2597-4B44-8FBD-DEFA6ACBD92B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27001230-CE049524-2597-4B44-8FBD-DEFA6ACBD92B
Experimental therapies and ongoing clinical trials to slow down progression of ADPKD
P2860
Q27001230-CE049524-2597-4B44-8FBD-DEFA6ACBD92B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27001230-CE049524-2597-4B44-8FBD-DEFA6ACBD92B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7d5b448d463ee99217522a1e6f2bdbd82fe2e6d5
P2860
Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells.